French Government Agrees to Fund Study of the PneumRx RePneu Lung Volume Reduction Coil

French Government Agrees to Fund Study of the PneumRx RePneu Lung Volume Reduction Coil PR Newswire MOUNTAIN VIEW, California, July 30, 2012 - French Government commits 1.3 Million Euros to fund cost-effectiveness study of the RePneu LVRC in 100 subjects at 10 centers throughout France MOUNTAIN VIEW, California, July 30, 2012 /PRNewswire/ -- PneumRx, Inc. (www.pneumrx.com), a leader in the field of interventional pulmonology, today announced that the French Ministry of Health has approved a cost- effectiveness study of the RePneu Lung Volume Reduction Coil (RePneu LVRC) in France. The Ministry of Health agreed to fund the study under the soutien aux techniques innovantes couteuses (STIC) program, which provides government funding for innovative medical technologies that have been validated by prior clinical studies, with a view toward establishing reimbursement for new devices. The PneumRx study is one of only two STIC projects selected by the Ministry of Health for funding in 2012, and the first in the field of emphysema treatment since 2006. The French Government has committed to paying 1.3 Million Euros ($1.6 Million) to support this PneumRx study.